Are you a new member? Sign up now
Login area
| Sign up
close
VIMPAT - 200mg - 56
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N03AX18 | B | Lacosamide - 200mg | 7472 | 185982/13 | VIMPAT | 200mg | 56 | Tablet, film coated | Oral | Sadco | Aesica Pharmaceuticals GmbH | Germany | 13,357,859 L.L | 19.35 | D | UCB Pharma SA | Belgium | 2/5/2024 | 0 |
Drug Substitutes
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N03AX18 | G | Lacosamide - 200mg | 10848 | 156219/1 | LACOSAMIDE/GENEPHARM | 200mg | 56 | Tablet | Oral | Nobel Pharm Plus SARL | Genepharm SA | Greece | 8,284,105 L.L | 21.26 | C | Genepharm SA | Greece | 2/5/2024 | 0 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024